Advertisement
UK markets open in 3 hours 35 minutes
  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     
  • HANG SENG

    17,624.10
    +339.56 (+1.96%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • GOLD FUTURES

    2,345.00
    +2.50 (+0.11%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,531.75
    +152.67 (+0.30%)
     
  • CMC Crypto 200

    1,390.47
    +7.90 (+0.57%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Top Ranked Momentum Stocks to Buy for July 24th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 24th:

Arena Pharmaceuticals, Inc. (ARNA): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 11.2% over the last 60 days.

Arena Pharmaceuticals, Inc. Price and Consensus

Arena Pharmaceuticals, Inc. Price and Consensus | Arena Pharmaceuticals, Inc. Quote

Arena Pharmaceuticals’ shares gained 61.6% over the last one month higher than S&P 500’s gains of 1.4%. The company possesses a Momentum Score of A.

ADVERTISEMENT

Arena Pharmaceuticals, Inc. Price

Arena Pharmaceuticals, Inc. Price | Arena Pharmaceuticals, Inc. Quote

Mettler-Toledo International Inc. (MTD): This manufacturer of precision instrumentshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

Mettler-Toledo International, Inc. Price and Consensus

Mettler-Toledo International, Inc. Price and Consensus | Mettler-Toledo International, Inc. Quote

Mettler-Toledo International’s shares gained 2.3% over the last one month. The company possesses a Momentum Score of A.

Mettler-Toledo International, Inc. Price

Mettler-Toledo International, Inc. Price | Mettler-Toledo International, Inc. Quote

Vertex Pharmaceuticals Incorporated (VRTX): This healthcare company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 27.5% over the last 60 days.

Vertex Pharmaceuticals Incorporated Price and Consensus

Vertex Pharmaceuticals Incorporated Price and Consensus | Vertex Pharmaceuticals Incorporated Quote

Vertex Pharmaceuticals’ shares gained 22.2% over the last one month. The company possesses a Momentum Score of A.

Vertex Pharmaceuticals Incorporated Price

Vertex Pharmaceuticals Incorporated Price | Vertex Pharmaceuticals Incorporated Quote

Dover Corporation (DOV): This manufacturer of industrial products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.

Dover Corporation Price and Consensus

Dover Corporation Price and Consensus | Dover Corporation Quote

Dover’s shares gained 5.6% over the last one month. The company possesses a Momentum Score of A.

Dover Corporation Price

Dover Corporation Price | Dover Corporation Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
 
Mettler-Toledo International, Inc. (MTD) : Free Stock Analysis Report
 
Dover Corporation (DOV) : Free Stock Analysis Report
 
Arena Pharmaceuticals, Inc. (ARNA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.